UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Why methamphetamine‐related deaths need more attention

Addiction (Abingdon, England), 2017-12, Vol.112 (12), p.2203-2204

McKetin, Rebecca

2017

Volltextzugriff (PDF)

Corrigendum to ‘Is there a discrete negative symptom dimension in people who use methamphetamine?’Comprehensive Psychiatry 93 (2019) 27–32

Comprehensive psychiatry, 2024-08, Vol.133, p.152231, Article 152231

2024

Volltextzugriff (PDF)

Methamphetamine and cardiovascular pathology: a review of the evidence

Addiction (Abingdon, England), 2007-08, Vol.102 (8), p.1204-1211

2007

Volltextzugriff (PDF)

Methamphetamine use and violence: Findings from a longitudinal birth cohort

Drug and alcohol dependence, 2020-02, Vol.207, p.107826-107826, Article 107826

2020

Volltextzugriff (PDF)

Major physical and psychological harms of methamphetamine use

Drug and alcohol review, 2008-05, Vol.27 (3), p.253-262

2008

Volltextzugriff (PDF)

Methamphetamine psychosis: insights from the past

Addiction (Abingdon, England), 2018-08, Vol.113 (8), p.1522-1527

McKetin, Rebecca

2018

Volltextzugriff (PDF)

Health‐related quality of life among people who use methamphetamine

Drug and alcohol review, 2019-07, Vol.38 (5), p.503-509

2019

Volltextzugriff (PDF)

The prevalence of psychotic symptoms among methamphetamine users

Addiction (Abingdon, England), 2006-10, Vol.101 (10), p.1473-1478

2006

Volltextzugriff (PDF)

Household surveys and the case of the Australian methamphetamine situation

Addiction (Abingdon, England), 2021-10, Vol.116 (10), p.2610-2611

McKetin, Rebecca

2021

Volltextzugriff (PDF)

Is there a discrete negative symptom syndrome in people who use methamphetamine?

Comprehensive psychiatry, 2019-08, Vol.93, p.27-32

2019

Volltextzugriff (PDF)

Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders

Psychiatry research, 2017-05, Vol.251, p.349-354

2017

Volltextzugriff (PDF)

Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis

EClinicalMedicine, 2019-11, Vol.16, p.81-97

2019

Volltextzugriff (PDF)

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

PloS one, 2022-10, Vol.17 (10), p.e0275371-e0275371

2022

Volltextzugriff (PDF)

Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology

Addiction (Abingdon, England), 2008-08, Vol.103 (8), p.1353-1360

2008

Volltextzugriff (PDF)

Virtual contingency management, what is it worth and who will pay for it?

Addiction (Abingdon, England), 2024-09, Vol.119 (9), p.1517-1518

2024

Volltextzugriff (PDF)

The relationship between crystalline methamphetamine use and methamphetamine dependence

Drug and alcohol dependence, 2006-12, Vol.85 (3), p.198-204

2006

Volltextzugriff (PDF)

The risk of psychotic symptoms associated with recreational methamphetamine use

Drug and alcohol review, 2010-07, Vol.29 (4), p.358-363

2010

Volltextzugriff (PDF)

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence

Addiction (Abingdon, England), 2009-02, Vol.104 (2), p.224-233

2009

Volltextzugriff (PDF)

Introduction to special section on precursor control

The International journal of drug policy, 2024-06, p.104458, Article 104458

2024

Volltextzugriff (PDF)

Amphetamine-type stimulant use and self-harm: protocol for a systematic review of observational studies

BMJ open, 2022-01, Vol.12 (1), p.e057029-e057029

2022

Volltextzugriff (PDF)

Six-month outcomes of a Web-based intervention for users of amphetamine-type stimulants: randomized controlled trial

Journal of medical Internet research, 2015-04, Vol.17 (4), p.e105-e105

2015

Volltextzugriff (PDF)

The rise of methamphetamine in Southeast and East Asia

Drug and alcohol review, 2008-05, Vol.27 (3), p.220-228

2008

Volltextzugriff (PDF)

A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence

Trials, 2019-06, Vol.20 (1), p.325-11, Article 325

2019

Volltextzugriff (PDF)

Emotion Recognition and Impulsive Choice in Relation to Methamphetamine Use and Psychosis Symptoms

Frontiers in psychiatry, 2019-12, Vol.10, p.889-889

2019

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Aktive Filter

KollektionPAIS Index

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Englisch
(163)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(131)
Methamphetamine
(100)
Substance Abuse
(99)
Humans
(95)
Adult
(63)
Female
(60)
Male
(59)
Psychiatry
(57)
Drug Abuse
(45)
Methamphetamine - Adverse Effects
(31)
Young Adult
(31)
Adolescent
(29)
Middle Aged
(29)
Psychosis
(29)
Mental Health
(27)
Amphetamine-Related Disorders - Epidemiology
(26)
Amphetamines
(26)
Drug Use
(24)
Amphetamine-Related Disorders - Psychology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Why methamphetamine‐related deaths need more attention

Corrigendum to ‘Is there a discrete negative symptom dimension in people who use methamphetamine?’Comprehensive Psychiatry 93 (2019) 27–32

Methamphetamine and cardiovascular pathology: a review of the evidence

Methamphetamine use and violence: Findings from a longitudinal birth cohort

Major physical and psychological harms of methamphetamine use

Methamphetamine psychosis: insights from the past

Health‐related quality of life among people who use methamphetamine

The prevalence of psychotic symptoms among methamphetamine users

Household surveys and the case of the Australian methamphetamine situation

Is there a discrete negative symptom syndrome in people who use methamphetamine?

Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders

Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology

Virtual contingency management, what is it worth and who will pay for it?

The relationship between crystalline methamphetamine use and methamphetamine dependence

The risk of psychotic symptoms associated with recreational methamphetamine use

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence

Introduction to special section on precursor control

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial

Amphetamine-type stimulant use and self-harm: protocol for a systematic review of observational studies

Six-month outcomes of a Web-based intervention for users of amphetamine-type stimulants: randomized controlled trial

The rise of methamphetamine in Southeast and East Asia

A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence

Emotion Recognition and Impulsive Choice in Relation to Methamphetamine Use and Psychosis Symptoms

Aktive Filter

Suchergebnisse filtern